JESSICA LEAL-PORRAS: Open Payments
NPI 1588721666 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,236 in 56 payments from 15 companies in 2025. Trend: 2023 $1,365 · 2024 $1,177 · 2025 $1,236
Food & beverage: $1,236
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $294 |
| Novo Nordisk Inc | 25 | $290 |
| AstraZeneca Pharmaceuticals LP | 5 | $157 |
| Dexcom, Inc. | 1 | $116 |
| Amgen Inc. | 6 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| Corcept Therapeutics | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| SANOFI PASTEUR INC. | 1 | $20 |
Products named: Wegovy, KISUNLA, Dexcom G6 Transmitter, ZEPBOUND, OTEZLA, BREZTRI, JARDIANCE, FARXIGA.
Industry payments across TX — which companies pay providers there.
